| Description | Upacicalcet (sodium) is an intravenous calcimimetic agent that acts directly on parathyroid cell membrane calcium-sensing receptors to suppress excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels. It is indicated for the research of secondary hyperparathyroidism (SHPT). |
| molecular weight | 374.75 |
| Molecular formula | C11H14ClN3NaO6S |
| CAS | 2052969-18-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Hoy SM. Upacicalcet: First Approval. Drugs. 2021;81(13):1593-1596. |